ID28984A - Fosfoglikolipid dan metoda penggunannya - Google Patents

Fosfoglikolipid dan metoda penggunannya

Info

Publication number
ID28984A
ID28984A IDW20010665A ID20010665A ID28984A ID 28984 A ID28984 A ID 28984A ID W20010665 A IDW20010665 A ID W20010665A ID 20010665 A ID20010665 A ID 20010665A ID 28984 A ID28984 A ID 28984A
Authority
ID
Indonesia
Prior art keywords
compound
deoxy
ischemia
damage due
reperfusion injury
Prior art date
Application number
IDW20010665A
Other languages
English (en)
Indonesian (id)
Inventor
Gary T Elliot
Patricia A Weber
Gregory C Sowell
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of ID28984A publication Critical patent/ID28984A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20010665A 1998-08-21 1999-08-18 Fosfoglikolipid dan metoda penggunannya ID28984A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/138,305 US6013640A (en) 1998-08-21 1998-08-21 Phosphoglycolipid and methods for its use

Publications (1)

Publication Number Publication Date
ID28984A true ID28984A (id) 2001-07-19

Family

ID=22481436

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010665A ID28984A (id) 1998-08-21 1999-08-18 Fosfoglikolipid dan metoda penggunannya

Country Status (19)

Country Link
US (2) US6013640A (de)
EP (1) EP1105401B1 (de)
JP (1) JP2002523420A (de)
KR (1) KR20010072806A (de)
CN (1) CN1324364A (de)
AT (1) ATE263776T1 (de)
AU (1) AU754186B2 (de)
BR (1) BR9913175A (de)
CA (1) CA2340649A1 (de)
CZ (1) CZ2001637A3 (de)
DE (1) DE69916289D1 (de)
HU (1) HUP0103473A3 (de)
ID (1) ID28984A (de)
IL (1) IL141496A0 (de)
NO (1) NO20010854L (de)
NZ (1) NZ510260A (de)
PL (1) PL349422A1 (de)
TR (1) TR200100636T2 (de)
WO (1) WO2000011010A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
WO2001090129A2 (en) 2000-05-19 2001-11-29 Corixa Corporation Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
AU8100101A (en) * 2000-08-04 2002-02-18 Corixa Corp New immunoeffector compounds
US7759803B2 (en) * 2001-07-25 2010-07-20 Rohm Co., Ltd. Semiconductor device and method of manufacturing the same
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
EP1482795B1 (de) * 2002-02-04 2009-11-11 Corixa Corporation Neue immuneffektor-verbindungen
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
BR0312656A (pt) * 2002-07-08 2005-06-07 Corixa Corp Processos para a produção de imunoefetores fosfato glicosaminìdeo de aminoalquila e dissacarìdeos e seus intermediários
US7288640B2 (en) * 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
US20050152835A1 (en) * 2003-10-31 2005-07-14 Pak Koon Y. Technetium-99M glucarate methods of use for monitoring tissues
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
US8697120B2 (en) * 2006-05-01 2014-04-15 Johns Hopkins University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
WO2008134830A1 (en) * 2007-03-22 2008-11-13 Fundação Butantan Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production
JP5562939B2 (ja) * 2008-04-09 2014-07-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル アクチン細胞骨格再編成及び細胞間ギャップ形成調節の方法
WO2026041647A1 (en) 2024-08-19 2026-02-26 Om Pharma Sa Small molecule targeting tlr4 overexpressing tumors and associated immunosuppressive, angiogenic and fibrotic complications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents

Also Published As

Publication number Publication date
US6399590B2 (en) 2002-06-04
ATE263776T1 (de) 2004-04-15
WO2000011010A1 (en) 2000-03-02
TR200100636T2 (tr) 2002-02-21
NO20010854L (no) 2001-04-20
IL141496A0 (en) 2002-03-10
US20020013291A1 (en) 2002-01-31
CA2340649A1 (en) 2000-03-02
HUP0103473A2 (hu) 2002-04-29
CZ2001637A3 (cs) 2001-10-17
CN1324364A (zh) 2001-11-28
AU754186B2 (en) 2002-11-07
KR20010072806A (ko) 2001-07-31
EP1105401A1 (de) 2001-06-13
BR9913175A (pt) 2001-10-09
US6013640A (en) 2000-01-11
HUP0103473A3 (en) 2003-01-28
NO20010854D0 (no) 2001-02-20
EP1105401B1 (de) 2004-04-07
JP2002523420A (ja) 2002-07-30
PL349422A1 (en) 2002-07-29
AU5683299A (en) 2000-03-14
NZ510260A (en) 2002-10-25
DE69916289D1 (de) 2004-05-13

Similar Documents

Publication Publication Date Title
PL349422A1 (en) Phosphoglycolipid and methods for its use
TR200101124T2 (tr) N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar.
BR9307235A (pt) M-todos para combater pneumonia de pneumocystis carinni e compostos Úteis para os mesmos
CA2261848A1 (en) Cell adhesion inhibitors
NO891082D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
GR3034099T3 (en) Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
YU20302A (sh) Upotreba retigabina u lečenju neuropatskog bola
BR8904263A (pt) Adjuvante apropriado para uso com agentes de protecao de culturas,composicoes herbicidas e processo para aumentar a eficacia de agentes de protecao de culturas
BR9708706B8 (pt) composição farmacêutica para administração intravenosa a um paciente
PT928788E (pt) Compostos farmaceuticamente activos
EA200500804A1 (ru) Топические противоинфекционные композиции
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
DE3463766D1 (en) Radioprotector agents with an aminothioalkyl structure, and process for their preparation
RU97104786A (ru) Раствор для защиты роговицы от повреждений "визиотон i"
NO174198C (no) Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav
AU1951499A (en) Use of mek1 inhibitors as protective agents against damage due to ischemia
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
EA199800658A1 (ru) Терапевтическое средство против астмы
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
NO840732L (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
JPS5513285A (en) Imidazoline compound and medical composition
DE3569458D1 (en) Agent for the protection of and for combating damage caused to the vegetation
PT985414E (pt) Metodo de tratamento de glaucoma e retinopatia isquemica